Shares of Stericycle, Inc. (NASDAQ:SRCL – Get Free Report) have earned a consensus rating of “Hold” from the five ratings firms that are currently covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and two have assigned a buy recommendation to the company. The average 12-month target price among analysts that have issued a report on the stock in the last year is $59.40.
Several research firms have commented on SRCL. Robert W. Baird decreased their price objective on shares of Stericycle from $62.00 to $55.00 and set a “neutral” rating for the company in a research note on Friday, April 26th. Royal Bank of Canada restated an “outperform” rating and set a $69.00 price target on shares of Stericycle in a research note on Thursday, March 7th. Wells Fargo & Company raised their price target on shares of Stericycle from $40.00 to $48.00 and gave the stock an “underweight” rating in a research note on Friday, March 1st. Truist Financial decreased their price target on shares of Stericycle from $57.00 to $50.00 and set a “hold” rating for the company in a research note on Monday. Finally, StockNews.com lowered shares of Stericycle from a “buy” rating to a “hold” rating in a research note on Tuesday, April 2nd.
Get Our Latest Report on Stericycle
Institutional Inflows and Outflows
Stericycle Trading Down 1.5 %
NASDAQ:SRCL opened at $44.73 on Friday. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.11 and a current ratio of 1.11. The firm has a market cap of $4.15 billion, a price-to-earnings ratio of -203.32, a price-to-earnings-growth ratio of 2.49 and a beta of 1.09. Stericycle has a 52 week low of $37.78 and a 52 week high of $57.06. The firm has a 50-day moving average price of $51.27 and a two-hundred day moving average price of $48.26.
Stericycle (NASDAQ:SRCL – Get Free Report) last posted its quarterly earnings data on Thursday, April 25th. The business services provider reported $0.57 EPS for the quarter, beating the consensus estimate of $0.54 by $0.03. The firm had revenue of $664.90 million during the quarter, compared to analyst estimates of $676.42 million. Stericycle had a negative net margin of 0.74% and a positive return on equity of 7.31%. The company’s revenue for the quarter was down 2.8% on a year-over-year basis. During the same quarter last year, the business posted $0.49 EPS. On average, equities analysts expect that Stericycle will post 2.32 earnings per share for the current fiscal year.
About Stericycle
Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.
Read More
- Five stocks we like better than Stericycle
- What to Know About Investing in Penny Stocks
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- What is Insider Trading? What You Can Learn from Insider Trading
- Hilton Demonstrates Asset Light is Right for Investors
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.